DeutschNewstral
Article
Bbarrons.com on 2023-07-18 15:16
Novartis Stock Climbs. It's All About a Hike in Outlook and $15 Billion Share Buyback. 1 min read
Related news
- BNovartis Stock Climbs. It's All About a Hike in Outlook and $15 Billion Share Buyback. 1 min readbarrons.com
- MRoche backs 2022 outlook as profit climbs, boosted by diagnostics sales1 min readmarketwatch.com
- MFedEx stock rallies on earnings beat, outlook hike, $5 billion share buyback plan1 min readmarketwatch.com
Novartis launches $5 billion share buyback, mulls Alcon spin-offReuters- MNovartis net income climbs as drug sales growmarketwatch.com
- MDollar climbs as Fed minutes point to December hikemarketwatch.com
- MNovartis prostate cancer drug trial meets primary endpoint1 min readmarketwatch.com
- MNovartis hemoglobinuria trial meets two primary endpoints1 min readmarketwatch.com
- BChegg Stock Climbs on Buyback Plan and Busuu Acquisition1 min readbarrons.com
- BBroadcom Shares Rally on Strong Earnings, Dividend Hike, Buyback Plan1 min readbarrons.com
- MArista Networks rises on earnings, outlook beat, share buyback, stock split1 min readmarketwatch.com
- BNovartis Stock Falls as Swiss Drugmaker Cuts Sales Outlook on Pandemic Woesbarrons.com
- MNovartis sales and profit drop, but backs 2022 guidance1 min readmarketwatch.com
- BNovartis Earnings Rise, Says Review of Sandoz Unit Progressing2 min readbarrons.com
- BNovartis CEO Vasant Narasimhan Sees Consistent Growth While Sitting on Cash4 min readbarrons.com
- BNovartis Will Cut Up to 8,000 Jobs Under CEO's Shake-Up Plan1 min readbarrons.com
- MGold climbs as Fed signals only one more rate hike to come1 min readmarketwatch.com
- BTapestry Beats Sales Estimates and Boosts Its Outlook. The Stock Climbs.1 min readbarrons.com
Fed facing a blurrier outlook as it meets to weigh rate hikeabqjournal.com